Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
For our clients considering Tirzepatide for weight management , we conduct a thorough assessment based on several factors, including Body Mass Index (BMI) and other health indicators
This triple-agonist approach combines appetite suppression, blood sugar regulation, and increased energy expenditure, which may help explain the greater weight loss seen in clinical trials
The trial, SURMOUNT-2, included 938 adult participants with obesity or overweight and type 2 diabetes
genetic factors determine whether you experience this theoretical advantage
References to clinical trials and published research throughout this description are provided for informational and research context only and do not constitute medical claims or endorsements of any therapeutic application of this product.
